Floaters and the quality of life

American Journal of Ophthalmology

Volumn 152, Issue 1, 2011, Pages

  Sebag, Jerry ^a,b  

^a VMR Institute   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC RETINOPATHY; DISEASE SEVERITY; HUMAN; LIFESPAN; LIGHT SCATTERING; NANOTECHNOLOGY; NOTE; OPHTHALMOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT PLANNING; VITREOUS FLOATERS; YAG LASER;

EID: 79959597446     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.02.015     Document Type: Editorial

References (16)

1. J. Sebag The diagnosis of health First Prize, National Essay Competition Preventive Medicine 8 1 1979 76 78
2. J. Sebag The VitreousStructure, Function and Pathobiology 1989 Springer-Verlag New York
3. J. Sebag, and K.M.P. Yee Vitreousfrom biochemistry to clinical relevance W. Tasman, E.A. Jaeger, Duane's Foundations of Clinical Ophthalmology, Vol. 1 2007 Lippincott Williams & Wilkins Philadelphia 1 67
4. M.W. Johnson Perifoveal vitreous detachment and its macular complications [thesis] Trans Am Ophthalmol Soc 103 2005 537 567 (Pubitemid 43042092)
5. J. Akiba, C.W. Arzabe, and C.L. Trempe Posterior vitreous detachment and neovascularization in diabetic retinopathy Ophthalmology 97 7 1990 889 891 (Pubitemid 20217938)
6. I. Krebs, W. Brannath, and K. Glittenberg Posterior vitreo-macular adhesion: a potential risk factor for exudative age-related macular degeneration Am J Ophthalmol 144 5 2007 741 746
7. C. Robison, I. Krebs, and S. Binder Vitreo-macular adhesion in active and end-stage age-related macular degeneration Am J Ophthalmol 148 1 2009 79 82
8. J. Sebag Anomalous PVDa unifying concept in vitreo-retinal diseases Graefes Arch Clin Exp Ophthalmol 242 8 2004 690 698 (Pubitemid 39242846)
9. A.M. Wagle, W.-Y. Lim, T.-P. Yap, K. Neelam, and K.-G. Au Eong Utility values associated with vitreous floaters Am J Ophthalmol 152 1 2011 60 65
10. J. Sebag Pharmacologic vitreolysis [guest editorial] Retina 18 1 1998 1 3
11. J. Sebag Pharmacologic vitreolysispremise and promise of the first decade [guest editorial] Retina 29 7 2009 871 874
12. J. Sebag Diabetic vitreopathy [guest editorial] Ophthalmology 103 2 1996 205 206
13. R.R. Ansari, S. Dunker, and K. Suh Quantitative molecular characterization of bovine vitreous and lens with non-invasive dynamic light scattering Exp Eye Res 73 6 2001 859 866 (Pubitemid 34112111)
14. M.B. Datiles, R.R. Ansari, and K.I. Suh Clinical detection of precataractous lens protein changes using dynamic light scattering Arch Ophthalmol 126 12 2008 1687 1693
15. J. Sebag Molecular biology of pharmacologic vitreolysis [thesis] Trans Am Ophthalmol Soc 103 2005 473 494 (Pubitemid 43042095)
16. J. Sebag, R.R. Ansari, and K.I. Suh Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients Graefes Arch Clin Exp Ophthalmol 245 4 2007 576 580 (Pubitemid 46477319)